These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7005589)

  • 1. [The behavior of blood insulin and glucose in diabetic nephropathy under CAPD].
    Thomae U; Kuhlmann H; Boos W; Herrmann M; Eberhard K
    Med Welt; 1980 Oct; 31(44):1599-601. PubMed ID: 7005589
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R; Gómez M; Olea C
    Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuous ambulatory peritoneal dialysis in terminal renal-insufficiency diabetics].
    Kuhlmann H; Thomae U; Herrmann M; Eberhard K
    Med Klin; 1981 Mar; 76(6):169-76. PubMed ID: 7015094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of the blood sugar level in patients with diabetic nephropathy undergoing CAPD].
    Numata I; Suzuki M
    Kango Gijutsu; 1987 Feb; 33(3):290-3. PubMed ID: 3646349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
    Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
    Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
    Abe T; Kusumi H; Kanazawa M
    Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of drugs affecting blood glucose in diabetic patients with renal failure.
    Charpentier G; Riveline JP; Varroud-Vial M
    Diabetes Metab; 2000 Jul; 26 Suppl 4():73-85. PubMed ID: 10922977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of glycemia in patients with diabetes mellitus and CKD.
    Lubowsky ND; Siegel R; Pittas AG
    Am J Kidney Dis; 2007 Nov; 50(5):865-79. PubMed ID: 17954300
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
    Anderson KE; Petersen PH
    Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities of insulin administration in diabetics with kidney failure during CAPD treatment].
    Thomae U; Kuhlmann H
    Med Welt; 1980 Aug; 31(34):1202-4. PubMed ID: 7001164
    [No Abstract]   [Full Text] [Related]  

  • 16. [The blood insulin equilibrium during periodic peritoneal dialysis in chronic renal insufficiency].
    Mirouze J; Mion C; Orsetti A; Jullien C
    J Urol Nephrol (Paris); 1967; 73(10):790-801. PubMed ID: 5596274
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CAPD - an alternative in the dialysis treatment of diabetics suffering from kidney failure?].
    Kuhlmann H; Thomae U
    Med Welt; 1980 Aug; 31(31-32):1140-4. PubMed ID: 7421548
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing glycemic control in patients with diabetes and end-stage renal failure.
    Ansari A; Thomas S; Goldsmith D
    Am J Kidney Dis; 2003 Mar; 41(3):523-31. PubMed ID: 12612974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.